Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

NIKA PHARMACEUTICALS, INC. (NIKA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

NIKA PHARMACEUTICALS, INC. (NIKA), most recent 12 months reported: net loss $78.14K. Latest balance sheet on file: liquid cash $2.93K, total debt $340.62K, net cash -$337.69K. From SEC filings. Others in Pharmaceutical Preparations: NovaBridge Biosciences · NewcelX Ltd. · Minerva Neurosciences, Inc. · Neurogene Inc. · Nkarta, Inc. · NOMAD POWER SOLUTIONS, INC. · NANOVIRICIDES, INC. · NeuroSense Therapeutics Ltd.

Stock screener

Watchlist